semaglutide 1 mg side effects Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, gallbladder disease, dehydration-related acute kidney injury Top 5 Common Semaglutide Side

Mounjaro and Ozempic, medications intended to treat type 2 diabetes, arent FDA approved to treat obesity

From its initial use in the treatment of type 2 diabetes to its expansion to 12 indications such as obesity, cardiovascular disease, chronic kidney disease, and metabolic dysfunction related fatty liver disease (MASLD), the annual sales of GLP-1 drugs exceeded 100 billion dollars, and its research and development funding reached a historical peak of 21.72 million dollars in 2025

Both carry theoretical proliferative concerns because elevated IGF-1 signaling has been associated with cancer promotion in epidemiological data

Clinical evidence backs this idea